DANIEL GONZÁLEZ NIETO, PHD

Head of Experimental Neurology Laboratory at Center for Biomedical Technology; Director Group of Health Sciences Technologies; Associate Professor for the graduate and master programs of Biomedical Engineering; Department of Photonics Technology and Bioengineering at the School of Telecommunications, Universidad Politécnica de Madrid.

He has been active in neurobiology for more than two decades. He has published more than 30 peer-reviewed papers and given numerous presentations at national and international meetings. He pioneered the combined use of stem cells and silk fibroin-based polymers for stroke therapeutics.

 

Presently his work focuses on the study of brain spreading depression/depolarization waves, EEG and sleep/wake cycle regulation and cortical field potentials as biomarkers for early diagnosis/prognosis in stroke and Alzheimer´s disease. He uses brain engineering approaches for biomaterial-based drug/cell delivery to support the sustained administration of neuroprotective compounds to salvage the cerebral tissue at risk of damage or/and neurogenic factors and diverse rehabilitative paradigms to rewire neural networks enhancing brain plasticity and recovery in stroke, Alzheimer´s and Parkinson´s diseases.